About iuvo Therapeutics

2017

founded

Düsseldorf

Headquarter

Potsdam

Branch Office

The pharmaceutical company iuvo Therapeutics, founded in 2017 and headquartered in Düsseldorf, pursues the goal of reliably supplying patients in Europe with cannabis-based medicine of the highest quality. To achieve this goal, iuvo, as an independent importer, manufacturer, and wholesaler, constantly expands its manufacturer partnerships and supply chains, which have been successfully GDP and GMP certified for years. Pharmacies and a selection of pharmaceutical wholesalers are part of iuvo‘s distribution network.
The company develops its pharmaceuticals based on the state of science and in cooperation with experts in cannabis therapy, supports doctors and pharmaceutical specialists through recognized, scientific training courses. iuvo Therapeutics is an active member of the Federal Association of Pharmaceutical Cannabinoid Companies.

Press Releases

iuvo Organizes Practice-relevant Online Training with Prof. Dr. Karst about Medical Cannabis

05.11.2021
Potsdam/ Hanover, November 5, 2021 – In collaboration with Prof. Dr. Matthias Karst from the Hannover Medical School (MHH) iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is organizing a practice-relevant online training course for doctors on cannabis‑based medicine (CBM) on November 17, 2021. The advanced training course “Insights into an efficient therapy with cannabis-based pharmaceuticals”, […]

iuvo Expands Sales Network with Established Partner Cansativa

04.11.2021
Düsseldorf / Frankfurt am Main, November 4, 2021 – iuvo Therapeutics GmbH (iuvo Therapeutics or iuvo) is expanding its sales network: Cansativa GmbH (Cansativa) now offers iuvo’s high-quality full-spectrum cannabis extracts. iuvo Therapeutics and Cansativa have entered into a strategic distribution partnership. The well-established wholesaler with a focus on cannabis-based pharmaceuticals has expanded its product […]

iuvo Strengthens Management Team with Experienced Industry Pioneer, Alexander Rieg

20.10.2021
Düsseldorf, October 2021 – iuvo Therapeutics GmbH is proud to announce Alexander Rieg has joined the management team as of October 2021. With his extensive experience in the sales and marketing of pharmaceuticals in Germany, Alexander Rieg founded and acted as managing director of GECA Pharma GmbH. One of the first fully licensed importers of […]

iuvo in the Media

iuvo Welcomes Alexander Rieg as New Part of the Management Team

20.10.2021

Iuvo Therapeutics Ltd Announces Initial Sales and Deliveries of Exclusive Full Spectrum Cannabinoid Extracts

23.06.2021

Iuvo Therapeutics Imports 20.000 Full Spectrum Cannabis Extract from Cann Group

14.05.2021

Iuvo Imports the Single Largest Cannabinoid Extract Shipment to Europe

04.05.2021

Image sources:

https://unsplash.com/photos/WYd_PkCa1BY